David Grimwade Award
In 2017, EHA established a new award in honor of the late David Grimwade, for his great involvement and contribution to the European Hematology Association and its scientific activities as Board Member, TRTH Co-Director and Chair of the Scientific Program Committee. He was internationally renowned for his translational research, particularly in the field of acute promyelocytic leukemia. Therefore, the award will be presented each year to honor leading and active basic and translational researchers in the field of hematology. Furthermore, candidature for this award is based on several criteria such as the support of European Hematology, area of expertise, eligibility, other awards, gender and country of origin.
Every year, the EHA Board selects a winner. The award is presented in the Opening Ceremony of the Annual Congress, in which the winner is invited to deliver a lecture.
EHA is proud to grant the David Grimwade Award 2019 to Professor Tsvee Lapidot (Weizmann Institute, Rehovot, Israel) for his groundbreaking research contributions to the understanding of the basic mechanisms that regulate hematopoietic stem cells (HSCs) in the bone marrow microenvironment. Studying the ability of infused hematopoietic stem cells to repopulate the bone marrow, his research led to major discoveries of a very complex system that regulates the homing of HSCs, their retention and survival within the bone marrow microenvironment and their egress to the peripheral blood. The microanatomy of the bone marrow, chemokines, interaction with the nervous system, metabolic alterations and the dark-light diurnal cycle – all participate in this tight regulation of HSCs life cycle. His research has contributed immensely to the understanding of normal and abnormal hematopoiesis and is highly relevant to the field of stem cell transplantation.
Professor Tsvee Lapidot, winner of the 2019 David Grimwade Award.